Coronavirus pandemic | JNU webinars on ‘Lessons from Ramayana’ to help students develop leadership skill during COVID crisis

The webinars on leadership skills will be held on May 2 and 3 from 4 pm to 6 pm and the registration for the same is open now

Moneycontrol News

April 29, 2020 / 19:05 IST

The Jawaharlal Nehru University (JNU) in Delhi will be organising a special webinar on ‘Leadership lessons from Ramayana’. It is being organized with the aim of engaging students in doing something productive during the coronavirus-induced lockdown and teaching them leadership skills necessary to deal with the COVID-19 situation better.

This lecture is part of a series of web sessions organised by the varsity to raise awareness on the novel coronavirus pandemic that has spread to several countries across the world killing more than 2 lakh people, including 1008 in India.

For live updates on coronavirus, click here

The webinars on leadership skills will be held on May 2 and 3 from 4 pm to 6 pm. They will be addressed by Professor Santosh Kumar Shukla from the university’s School of Sanskrit and Indic Studies and Professor Mazha Asif from JNU’s School of Language, Literature, and Cultural Studies.

The registration for the course is open now, however, it will only be accessible to the students and faculty of the university.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show